164 related articles for article (PubMed ID: 31906724)
1. Breast Cancer With Brain Metastases: Perspective From a Long-Term Survivor.
Kofron CP; Chapman A
Integr Cancer Ther; 2020; 19():1534735419890017. PubMed ID: 31906724
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
Larsen PB; Kümler I; Nielsen DL
Cancer Treat Rev; 2013 Nov; 39(7):720-7. PubMed ID: 23481218
[TBL] [Abstract][Full Text] [Related]
3. Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
Glück S; Castrellon A
Am J Ther; 2009; 16(6):585-90. PubMed ID: 19287304
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.
Labidi SI; Bachelot T; Ray-Coquard I; Mosbah K; Treilleux I; Fayette J; Favier B; Galy G; Blay JY; Guastalla JP
Clin Breast Cancer; 2009 May; 9(2):118-21. PubMed ID: 19433393
[TBL] [Abstract][Full Text] [Related]
5. [Systemic treatment of brain metastases from breast cancer].
Taillibert S; Conforti R; Bonneterre J; Bachelot T; Le Rhun E; Bernard-Marty C
Cancer Radiother; 2015 Feb; 19(1):36-42. PubMed ID: 25662600
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review.
Ricciardi GRR; Russo A; Franchina T; Schifano S; Mastroeni G; Santacaterina A; Adamo V
BMC Cancer; 2018 Jan; 18(1):97. PubMed ID: 29370839
[TBL] [Abstract][Full Text] [Related]
7. HER2-positive breast cancer brain metastases: multiple responses to systemic chemotherapy and trastuzumab--a case report.
Church DN; Bahl A; Jones A; Price CG
J Neurooncol; 2006 Sep; 79(3):289-92. PubMed ID: 16821088
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.
Bai B; Yuan ZY; Liu DG; Teng XY; Wang SS
Chin J Cancer; 2010 Apr; 29(4):413-9. PubMed ID: 20346218
[TBL] [Abstract][Full Text] [Related]
9. Impressive Long-term Response with Pertuzumab and Trastuzumab in HER2-positive Breast Cancer with Brain Metastasis.
Russillo M; Ferretti G; Vidiri A; Gasparro S; Cognetti F; Pellegrini D; Fabi A
In Vivo; 2018; 32(4):839-842. PubMed ID: 29936468
[TBL] [Abstract][Full Text] [Related]
10. Activity of T-DM1 in Her2-positive breast cancer brain metastases.
Bartsch R; Berghoff AS; Vogl U; Rudas M; Bergen E; Dubsky P; Dieckmann K; Pinker K; Bago-Horvath Z; Galid A; Oehler L; Zielinski CC; Gnant M; Steger GG; Preusser M
Clin Exp Metastasis; 2015 Oct; 32(7):729-37. PubMed ID: 26303828
[TBL] [Abstract][Full Text] [Related]
11. The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death.
Niwińska A; Tacikowska M; Murawska M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1134-9. PubMed ID: 19932944
[TBL] [Abstract][Full Text] [Related]
12. [Trastuzumab emtansine in the systemic treatment of HER-2-positive breast cancer brain metastases].
Frenel JS; Bally O; Bourbouloux E; Berton-Rigaud D; Campone M; Bachelot T; Heudel PÉ
Bull Cancer; 2016 May; 103(5):507-10. PubMed ID: 26992855
[No Abstract] [Full Text] [Related]
13. [Systemic treatment of brain metastases from breast cancer: cytotoxic chemotherapy and targeted therapies].
Bachelot T; Le Rhun E; Labidi-Gally I; Heudel P; Gilabert M; Bonneterre J; Pierga JY; Gonçalves A
Bull Cancer; 2013 Jan; 100(1):7-14. PubMed ID: 23305997
[TBL] [Abstract][Full Text] [Related]
14. Early-onset brain metastases in a breast cancer patient after pathological complete response to neoadjuvant chemotherapy.
Shimada K; Ishikawa T; Yoneyama S; Kita K; Narui K; Sugae S; Shimizu D; Tanabe M; Sasaki T; Chishima T; Ichikawa Y; Endo I
Anticancer Res; 2013 Nov; 33(11):5119-21. PubMed ID: 24222158
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab therapy may contribute to irradiation deferral in patients with breast cancer and with central nervous system metastases: findings of a case series.
Kountourakis P; Dokou A; Kardara E; Kaltsas S; Doufexis D; Tzovaras A; Mourgela S; Ardavanis A
Clin Breast Cancer; 2012 Aug; 12(4):282-6. PubMed ID: 22609269
[No Abstract] [Full Text] [Related]
16. Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
Ramakrishna N; Temin S; Chandarlapaty S; Crews JR; Davidson NE; Esteva FJ; Giordano SH; Kirshner JJ; Krop IE; Levinson J; Modi S; Patt DA; Perlmutter J; Winer EP; Lin NU
J Clin Oncol; 2018 Sep; 36(27):2804-2807. PubMed ID: 29939840
[TBL] [Abstract][Full Text] [Related]
17. HER2-positive metastatic breast cancer: a changing scenario.
Mustacchi G; Biganzoli L; Pronzato P; Montemurro F; Dambrosio M; Minelli M; Molteni L; Scaltriti L
Crit Rev Oncol Hematol; 2015 Jul; 95(1):78-87. PubMed ID: 25748080
[TBL] [Abstract][Full Text] [Related]
18. [A case of advanced breast cancer with multiple lung and liver metastases successfully treated with multi-disciplinary therapy].
Sakurai K; Enomoto K; Amano S; Kitajima A; Suzuki M; Matsuo S; Sakamoto A; Kashio M; Tani M; Negishi N
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1792-4. PubMed ID: 16315943
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases.
Lin NU; Freedman RA; Ramakrishna N; Younger J; Storniolo AM; Bellon JR; Come SE; Gelman RS; Harris GJ; Henderson MA; Macdonald SM; Mahadevan A; Eisenberg E; Ligibel JA; Mayer EL; Moy B; Eichler AF; Winer EP
Breast Cancer Res Treat; 2013 Nov; 142(2):405-14. PubMed ID: 24197661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
